RANBAXY UNIT GETS FDA WARNING LETTER

被引：0

|

作者：

不详

机构：

来源：

CHEMICAL & ENGINEERING NEWS | 2010年 / 88卷 / 02期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：21 / 21

页数：1

相关论文

共 50 条

[1] CAMBREX GETS FDA WARNING LETTER
不详
CHEMICAL & ENGINEERING NEWS, 2009, 87 (35) : 17 - 17
[2] FDA issues warning letter
不详
FOOD TECHNOLOGY, 2007, 61 (06) : 12 - 13
[3] Gilead Sciences Receives FDA Warning Letter
Sethi, Chitra
BIOPHARM INTERNATIONAL, 2010, 23 (11) : 12 - 12
[4] RANBAXY RUNS AFOUL OF FDA, AGAIN
不详
CHEMICAL & ENGINEERING NEWS, 2014, 92 (05) : 13 - 13
[5] Ranbaxy censured by FDA over falsified data
Nature, 2009, 458 (7234) : 20 - 20
[6] FDA WARNING LETTER ANALYSIS: A TOOL FOR GMP COMPLIANCE
Patel, Darshit S.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (12): : 4592 - 4603
[7] Flu vaccine manufacturer receives FDA warning letter
Holland-Moritz, Pam
BIOPHARM INTERNATIONAL, 2006, 19 (08) : 20 - 20
[8] Ranbaxy troubles place FDA under fire
Trager, Rebecca
CHEMISTRY WORLD, 2008, 5 (09): : 17 - 17
[9] FDA TAKES MORE ACTION AGAINST RANBAXY
不详
CHEMICAL & ENGINEERING NEWS, 2009, 87 (09) : 30 - 30
[10] An Analysis of FDA Warning Letter Citations from 2019-2023
Kwiecinski, George
JOURNAL OF PHARMACEUTICAL INNOVATION, 2024, 19 (06)

← 1 2 3 4 5 →